capecitabine

Type: Keyphrase
Name: capecitabine
First reported 44 mins ago - Updated 44 mins ago - 1 reports

Forum Post: Capecitabine & ache in chest

Hi,I've just finished my 6th cycle of capecitabine (I'm probably spelling it wrong, so my apologies, I've never bothered to learn how to spell it, probably due to how it makes me feel!) and I'm beginning to feel a dull ache in my chest.I don't have a ... [Published Macmillan Cancer Support - 44 mins ago]
First reported Sep 28 2014 - Updated Sep 28 2014 - 1 reports

Forum Post: RE: Secondary bone cancer with liver involvement.

Bone, secondary cancerSecondary bone cancer is cancer that has spread to the bones from a primary cancer somewhere else in the body. This group is for people affected by secondary bone cancer to share experiences and get support.Secondary bone cancer ... [Published Macmillan Cancer Support - Sep 28 2014]
First reported Sep 28 2014 - Updated Sep 28 2014 - 1 reports

Generic Capecitabine NO PRESCRIPTION Required, Capecitabine Shipped Overnight Witho

generic capecitabine NO PRESCRIPTION Required, capecitabine shipped overnight without a prescriptionMed Portal has proved its reliability and safety, working at pharmaceutical market since 2003. One of the most urgent problems in online pharmacy business ... [Published Student Village - Sep 28 2014]
First reported Sep 26 2014 - Updated Sep 26 2014 - 2 reports

Halaven (Eribulin) Provides Clinical Benefit Without an Adverse Effect on Quality of Life: Data Presented at ESMO

/PRNewswire/ --FOR EMEA MEDIA ONLY: NOT FOR SWISS/U.S. JOURNALISTSAdditional Pooled Phase III Data Presented at ESMO Show Significantly Improved Overall Survival for Eribulin Compared to Standard Therapies in Locally Advanced or Metastatic Breast Can ... [Published FinanzNachrichten.de - Sep 26 2014]
First reported Sep 25 2014 - Updated Sep 25 2014 - 1 reports

Cost-Effectiveness of Aspirin Adjuvant Therapy in Early Stage Colorectal Cancer in Older Patients

by Swee Sung Soon, Whay-Kuang Chia, Mun-ling Sarah Chan, Gwo Fuang Ho, Xiao Jian, Yan Hong Deng, Chuen-Seng Tan, Atul Sharma, Eva Segelov, Shaesta Mehta, Raghib Ali, Han-Chong Toh, Hwee-Lin WeeBackground & AimsRecent observational studies showed that ... [Published Plosone.org - Sep 25 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 2 reports

Nab-paclitaxel Cost Not Justified by Limited Benefit, Says NICE

NICE has published new draft guidance which recommends that nab-paclitaxel taken with gemcitabine should not be funded by the NHS for previously untreated metastatic pancreatic cancer, because it has limited benefits compared to current treatments and ... [Published PharmaAsia - Sep 16 2014]
First reported Sep 14 2014 - Updated Sep 14 2014 - 1 reports

Forum Post: RE: chemo type for oesophagus / secondary liver

chemo type for oesophagus / secondary liverPosted by brian 3 on14 Sep 2014 11:19 AMhas anyone been given or had a relative given FOLFIRINOX FOR gullet /secondary liver cancer ,, been offered this , also been offered CAPECITABINE (XELODA) AND IRINOTECAN ... [Published Macmillan Cancer Support - Sep 14 2014]
First reported Sep 09 2014 - Updated Sep 09 2014 - 2 reports

The cost of nab-paclitaxel is not justified by its limited benefit, says NICE in draft guidance

NICE has published new draft guidance which recommends that nab-paclitaxel taken with gemcitabine should not be funded by the NHS for previously untreated metastatic pancreatic cancer, because it has limited benefits compared to current treatments and ... [Published FiercePharma - Sep 09 2014]
First reported Sep 05 2014 - Updated Sep 05 2014 - 1 reports

Taxane resistance trial shows promise

Taxane resistance is a serious problem linked to more aggressive forms of breast cancer.Posted: 5 September 2014Until now few studies and no international standard guidelines have been available on how to best treat resistant breast cancers but the results ... [Published PrimaryCare Today - Sep 05 2014]
First reported Sep 04 2014 - Updated Sep 04 2014 - 1 reports

Phase I Study of Sunitinib in Combination With Gemcitabine and Capecitabine for First-Line RCC Treatment

The combination of gemcitabine plus capecitabine and sunitinib (GCS) shows activity in metastatic renal cell carcinoma (mRCC). 09/04/2014 ... [Published News from Kidney Cancer Association - Sep 04 2014]
First reported Sep 01 2014 - Updated Sep 01 2014 - 1 reports

Forum Post: Capecitabine (Xeloda) starting thursday and feel like Im back to square one

Breast, secondary cancerSecondary breast cancer is cancer that has started in the breast and spread to other parts of the body. This group is for people affected by secondary breast cancer to share experiences and get support.Capecitabine (Xeloda) starting ... [Published Macmillan Cancer Support - Sep 01 2014]
First reported Sep 01 2014 - Updated Sep 01 2014 - 1 reports

Human medicines European public assessment report (EPAR): Capecitabine Medac, capecitabine, Revision: 3, Authorised

Entities: capecitabine

Quotes

In a recent report, targeted phage can be used to direct an immune response to a tumor site (Eriksson, et al. 2006 "Tumor specific phage particles promote tumor regression in a mouse melanoma" Cancer Immunol Immunother Pub online September 12)...
Eisai Co Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. We define our corporate mission as "giving first thought to patients and their families and to increasing the benefits health care provides" which we call our human healthhealth care (hhc) philosophy...
...is proud to support the research efforts of investigators at NCCN Member Institutions," said Robert W Carlson, MD, Chief Executive Officer, NCCN. "These grants, funded by Boehringer Ingelheim, allow researchers to further advance evidence-based medicine through clinical trials at world-class academic cancer centers."
NEXT ARTICLE More From BioPortfolio on "Roche’s Avastin and Xeloda show benefit for women with HER2-negative metastatic breast cancer in two new Phase III studies"

More Content

All (103) | News (74) | Reports (0) | Blogs (27) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Forum Post: Capecitabine & ache in chest [Published Macmillan Cancer Support - 44 mins ago]
Liposome composition for targeting egfr receptor [Published PharmCast - Sep 28 2014]
Forum Post: RE: Secondary bone cancer with live... [Published Macmillan Cancer Support - Sep 28 2014]
Generic Capecitabine NO PRESCRIPTION Required, ... [Published Student Village - Sep 28 2014]
Forum Post: Secondary bone cancer with liver in... [Published Macmillan Cancer Support - Sep 27 2014]
Halaven (Eribulin) Provides Clinical Benefit Wi... [Published FinanzNachrichten.de - Sep 26 2014]
Bevacizumab/Capecitabine Combo Shows Promise in... [Published PT Community - Sep 26 2014]
Metastatic Colorectal Cancer: Therapy Update fr... [Published Oncology Times - Sep 26 2014]
Variations in the Blood Phenytoin Levels during... [Published Sexual Development - Sep 25 2014]
NCCN ORP awards four research grants to advance... [Published News-Medical.Net - Sep 25 2014]
Roches Avastin and Xeloda show benefit for wome... [Published BioPortfolio - Sep 25 2014]
Roche cancer drugs show positive results in two... [Published Seeking Alpha - Sep 25 2014]
Bayer to present data from oncology portfolio, ... [Published PharmaBiz - Sep 25 2014]
Cost-Effectiveness of Aspirin Adjuvant Therapy ... [Published Plosone.org - Sep 25 2014]
ESMO 2014 to Feature New Oncology Data from Acr... [Published Scottrade - Sep 24 2014]
ESMO 2014 to Feature New Oncology Data from Acr... [Published TickerTech.com - Sep 24 2014]
EORTC presentations at ESMO 2014 Congress [Published Press News.org - Sep 23 2014]
Forum Post: RE: Finally starting my treatment. [Published Macmillan Cancer Support - Sep 22 2014]
Area cancer specialists co-authored articles in... [Published Herald News - Sep 19 2014]
HER2 in Trastuzumab/Emtansine vs Trastuzumab/Do... [Published General Medicine eJournal - Sep 19 2014]
ONLINE FIRST: Encouraging Outcomes in Pancreati... [Published Oncology Times - Sep 18 2014]
Roche to present latest oncology advances durin... [Published European Pharmaceutical Review - Sep 17 2014]
ROCHE BEARER SHARE : to present latest oncology... [Published 4 Traders - Sep 17 2014]
Chemotherapy And SABR Consecutively May Be Prom... [Published ScienceNewsline - Sep 17 2014]
Potentially Curative Surgery Achievable With Ch... [Published OncLive - Sep 17 2014]
New Halaven (Eribulin) and Lenvatinib Data to b... [Published FinanzNachrichten.de - Sep 17 2014]
Nab-paclitaxel Cost Not Justified by Limited Be... [Published PharmaAsia - Sep 16 2014]
Excellent Biochemical Response to Polychemother... [Published Sexual Development - Sep 16 2014]
NICE Recommends Against Coverage of Celgene’s C... [Published FDA News - Sep 16 2014]
Forum Post: RE: chemo type for oesophagus / sec... [Published Macmillan Cancer Support - Sep 14 2014]
1 2 3 4
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Phase I Study of Sunitinib in Combination With ... [Published News from Kidney Cancer Association - Sep 04 2014]
The combination of gemcitabine plus capecitabine and sunitinib (GCS) shows activity in metastatic renal cell carcinoma (mRCC). 09/04/2014 ...
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Sep 01 2014]
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Aug 29 2014]
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Aug 29 2014]
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Aug 29 2014]
1 2 3 4 5 6
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.